Cover Image
市場調查報告書

妊娠檢查裝置的全球市場 - 至2020年的預測:各產品 (OPK、妊娠監測)、購買方法 (處方箋、OTC)、地區

Fertility Testing Devices Market Product (Ovulation Prediction Kit & Fertility Monitor (Urine-based, Saliva-based, & Basal Body Temperature)), Mode of Purchase (Prescription & OTC), and Region - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 357481
出版日期 內容資訊 英文 123 Pages
訂單完成後即時交付
價格
Back to Top
妊娠檢查裝置的全球市場 - 至2020年的預測:各產品 (OPK、妊娠監測)、購買方法 (處方箋、OTC)、地區 Fertility Testing Devices Market Product (Ovulation Prediction Kit & Fertility Monitor (Urine-based, Saliva-based, & Basal Body Temperature)), Mode of Purchase (Prescription & OTC), and Region - Global Forecast to 2020
出版日期: 2016年04月11日 內容資訊: 英文 123 Pages
簡介

全球妊娠檢查裝置市場,至2020年擴大到2億1,680萬美元。市場預計2016年∼2020年以7.5%的年複合成長率成長。

本報告提供全球妊娠檢查裝置市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 妊娠檢查裝置市場概要
  • 各地區分析:各產品
  • 妊娠檢查裝置市場:各購買方法

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題
  • 產業趨勢

第6章 妊娠檢查裝置市場:各產品

  • 簡介
  • 排卵預測套件 (OPK)
  • 妊娠監測

第7章 妊娠檢查裝置市場:各購買方法

  • 簡介
  • 非處方箋/OTC
  • 處方箋

第8章 妊娠檢查裝置市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形與趨勢
  • 最近的發展

第10章 企業簡介 (財務、產品與服務、主要策略、最近的發展等)

  • 簡介
  • SPD SWISS PRECISION DIAGNOSTICS GMBH
  • CHURCH & DWIGHT CO., INC.
  • PRESTIGE BRANDS HOLDINGS, INC.
  • FAIRHAVEN HEALTH, LLC
  • HILIN LIFE PRODUCTS, INC.
  • FERTILITY FOCUS LIMITED
  • BABYSTART LTD
  • BIOZHENA CORPORATION
  • TAIDOC TECHNOLOGY CORPORATION
  • GERATHERM MEDICAL AG
  • UEBE MEDICAL GMBH

第11章 附錄

目錄
Product Code: MD 4215

The global fertility testing devices market is poised to reach USD 216.8 million by 2020 at a CAGR of 7.5% during the forecast period. The market for fertility testing devices is expected to witness high growth in the Asia-Pacific region. Factors such as decreasing fertility rate, growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors, and growing focus of both international and domestic players on the Asia-Pacific fertility testing devices market are driving the growth of the market in this region.

In this report, the global fertility testing devices market has been segmented into ovulation prediction kits and fertility monitors. The fertility monitors segment is classified into saliva-based monitors, urine-based monitors and others.

The ovulation prediction kits market held the larger share of the global fertility testing devices market in 2015. This is because ovulation kits provide more accurate results than natural fertility testing techniques. In addition, these kits are easier to use and less expensive than fertility monitors. However, the fertility monitors market is estimated to grow at the higher CAGR from 2015 to 2020.

Geographically, North America commanded the largest share of the global fertility testing devices market in 2015, followed by Europe. A number of factors such as decline in fertility rate owing to the rising first-time pregnancy age and high prevalence of PCOS (polycystic ovary syndrome) among North American women, increasing awareness about the benefits offered by ovulation monitors and fertility awareness methods (FAM) in successful conception among women, and the development of advanced low-cost devices are expected to support market growth in North America. However, stringent regulatory policies for the approval of medical devices, increasing government pressure to reduce healthcare costs, and rising adoption of low-cost ovulation monitors (resulting in lower revenue growth) are restraining the growth of the fertility testing devices market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of the global fertility testing devices market in the next five years.

The global fertility testing devices market is highly competitive, with a large number of small market players. As of 2014, the global fertility testing devices market was dominated by SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.), which accounted for a market share of more than 50% in 2014. Other players in this market include Geratherm Medical AG (Germany), HiLin Life Products, Inc. (U.S.), Fairhaven Health, LLC (U.S.), and Fertility Focus Limited (U.K.). New product development, partnerships, agreements, and collaboration are the major strategies adopted by most of the players to achieve growth in the fertility testing devices market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the fertility testing devices market, high growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities. The abovementioned market research data, current market size, and forecast of future trends will help existing players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, R&D investments for innovation in products and technologies, and levels of output in order to remain successful.

Firms purchasing the report could use any one or combination of the below-mentioned five strategies (Market Penetration, Product Development/Innovation, Market Diversification, and Competitive Assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the fertility testing devices offered by the top 10 players in the global fertility testing devices market. The report analyzes the fertility testing devices market by product and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various fertility testing devices across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global fertility testing devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global fertility testing devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. STRATEGIC RECOMMENDATIONS
  • 3.5. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. FERTILITY TESTING DEVICES MARKET OVERVIEW
  • 4.2. REGIONAL ANALYSIS: FERTILITY TESTING DEVICES MARKET, BY PRODUCT, 2015 VS. 2020(USD MILLION)
  • 4.3. FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE, 2013-2020(USD MILLION)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Rising median age of first-time pregnancies in women
      • 5.3.1.2. Declining fertility rate among women across the globe
      • 5.3.1.3. Emergence of advanced, easy-to-use ovulation monitors with high accuracy
      • 5.3.1.4. Increasing awareness about fertility testing among woman
      • 5.3.1.5. Easy availability of ovulation monitors on e-commerce websites
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Increasing inflow of generic fertility testing devices affecting revenue growth
      • 5.3.2.2. A majority of the modern ovulation prediction methods lack either the predictive power or precision to confirm ovulation
      • 5.3.2.3. Unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients
      • 5.3.2.4. High cost of ovulation monitors
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emergence of combined kits for dual testing of pregnancy and ovulation
      • 5.3.3.2. High untapped potential for fertility testing monitors
      • 5.3.3.3. Emerging nations to pave new growth avenues
      • 5.3.3.4. High cost and low success rate of IVF treatments
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Increasing trend towards childlessness in couples
      • 5.3.4.2. Increasing use of ovulation tracker mobile apps and fertility-tracking websites
  • 5.4. INDUSTRY TRENDS
      • 5.4.1.1. Rising adoption of basal body temperature-based ovulation monitors
      • 5.4.1.2. Increasing promotional activities by manufacturers highlighting the efficacy of ovulation tests
      • 5.4.1.3. Rising focus of market players on emerging regions

6. FERTILITY TESTING DEVICES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. OVULATION PREDICTION KITS
  • 6.3. FERTILITY MONITORS
    • 6.3.1. SALIVA-BASED MONITORS
    • 6.3.2. URINE-BASED MONITORS
    • 6.3.3. OTHERS

7. FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE

  • 7.1. INTRODUCTION
  • 7.2. NON-PRESCRIPTION OR OTC-BASED MODE OF PURCHASE
  • 7.3. PRESCRIPTION-BASED MODE OF PURCHASE

8. FERTILITY TESTING DEVICES MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. HIGH PREVALENCE OF INFERTILITY AND RISING AWARENESS ABOUT FERTILITY TESTING
    • 8.2.2. U.S.
      • 8.2.2.1. High demand for ovulation monitors in the U.S.
      • 8.2.2.2. Rising impaired fecundity rates - Leading cause of infertility in the U.S.
      • 8.2.2.3. Rising awareness about FAM and novel ovulation monitors
      • 8.2.2.4. Development of advanced fertility testing products
      • 8.2.2.5. Growing use of over-the-counter ovulation tests resulting in a greater demand for price reduction
    • 8.2.3. CANADA
      • 8.2.3.1. High cost of IVF to offer new growth opportunities for ovulation monitors in Canada
      • 8.2.3.2. Growth in first-child-bearing age
  • 8.3. EUROPE
    • 8.3.1. RISING FIRST-TIME PREGNANCY AGE IN EUROPE
    • 8.3.2. INCREASING OBESITY RATE IN EUROPE
    • 8.3.3. RISING FINANCIAL SUPPORT TO SUPPORT CHILD BIRTH IN EUROPE
    • 8.3.4. HIGH HEALTHCARE EXPENDITURE
    • 8.3.5. PRESENCE OF ADAPTIVE REGULATORY POLICIES
    • 8.3.6. RISING COST-CONTAINMENT MEASURES LIMITING THE PROFITABILITY OF MANUFACTURERS
    • 8.3.7. GERMANY
      • 8.3.7.1. Declining fertility rate among childbearing women in Germany
      • 8.3.7.2. Growing adoption of sedentary lifestyle
      • 8.3.7.3. High per capita disposable income
      • 8.3.7.4. Rising awareness about the benefits of ovulation monitors
      • 8.3.7.5. High preference for natural cycle monitoring methods
    • 8.3.8. U.K.
      • 8.3.8.1. Growing government initiatives towards training and skill development
      • 8.3.8.2. Large pool of patients suffering from PCOS
      • 8.3.8.3. Easy availability of ovulation monitors due to strong presence of leading market players
    • 8.3.9. FRANCE
      • 8.3.9.1. Rising median age for first-time pregnancy and rising obesity rate in France
      • 8.3.9.2. Establishment of appropriate guidelines and protocols for POC testing devices
    • 8.3.10. REST OF EUROPE
      • 8.3.10.1. Easy availability of ovulation monitors through distributors and e-commerce websites
      • 8.3.10.2. Decrease in healthcare expenditure in key RoE countries - A major market restraint
  • 8.4. ASIA-PACIFIC
    • 8.4.1. DECREASING FERTILITY RATE
    • 8.4.2. HIGH AVERAGE AGE OF MOTHERS AT FIRST CHILDBIRTH IN JAPAN
    • 8.4.3. RAPID INCREASE IN HEALTHCARE SPENDING IN THE ASIAN REGION
    • 8.4.4. LUCRATIVE HEALTHCARE MARKET FOR FERTILITY AND OVULATION MONITORS
    • 8.4.5. GROWING FOCUS OF LEADING PLAYERS ON THE ASIA-PACIFIC MARKET
    • 8.4.6. STRONG PRESENCE OF SMALL PLAYERS THAT OFFER LOW-COST FERTILITY TESTING PRODUCTS
    • 8.4.7. INCREASING REGULATORY BARRIERS IN AUSTRALIA
  • 8.5. REST OF THE WORLD (ROW)
    • 8.5.1. INCREASING INCIDENCE OF RISK FACTORS CAUSING INFERTILITY
    • 8.5.2. EXPANDING MIDDLE-CLASS POPULATION AND RISING DISPOSABLE INCOME IN LATIN AMERICA
    • 8.5.3. GROWTH IN PER CAPITA HEALTHCARE SPENDING
    • 8.5.4. GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE AND DECREASE TRADE BARRIERS
    • 8.5.5. ONGOING RECESSION AND HEAVY MEDICAL DEVICE TRAFFIC IN LATIN AMERICA

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. MARKET SHARE ANALYSIS
    • 9.2.1. KEY PLAYERS IN THE FERTILITY TESTING DEVICES MARKET
  • 9.3. COMPETITIVE SITUATION AND TRENDS
  • 9.4. RECENT DEVELOPMENTS
    • 9.4.1. NEW PRODUCT LAUNCHES
    • 9.4.2. AWARENESS PROGRAMS
    • 9.4.3. AGREEMENTS, PARTNERSHIPS, AND EXPANSION
    • 9.4.4. OTHER STRATEGIES

10. COMPANY PROFILES*

  • 10.1. INTRODUCTION
  • 10.2. SPD SWISS PRECISION DIAGNOSTICS GMBH
  • 10.3. CHURCH & DWIGHT CO., INC.
  • 10.4. PRESTIGE BRANDS HOLDINGS, INC.
  • 10.5. FAIRHAVEN HEALTH, LLC
  • 10.6. HILIN LIFE PRODUCTS, INC.
  • 10.7. FERTILITY FOCUS LIMITED
  • 10.8. BABYSTART LTD
  • 10.9. BIOZHENA CORPORATION
  • 10.10. TAIDOC TECHNOLOGY CORPORATION
  • 10.11. GERATHERM MEDICAL AG
  • 10.12. UEBE MEDICAL GMBH

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

11. APPENDIX

  • 11.1. INSIGHTS OF INDUSTRY EXPERTS
  • 11.2. DISCUSSION GUIDE
  • 11.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 2: OVULATION PREDICTION KITS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 3: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 4: FERTILITY MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: SALIVA-BASED FERTILITY MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: URINE-BASED FERTILITY MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: OTHER FERTILITY MONITORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 9: NON-PRESCRIPTION OR OTC-BASED FERTILITY TESTING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: PRESCRIPTION-BASED FERTILITY TESTING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: FERTILITY TESTING DEVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: NORTH AMERICA: FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: NORTH AMERICA: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 14: NORTH AMERICA: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 15: NORTH AMERICA: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 16: U.S.: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 17: U.S.: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 18: U.S.: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 19: CANADA: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 20: CANADA: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: CANADA: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 22: EUROPE: FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: EUROPE: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 24: EUROPE: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: EUROPE: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 26: GERMANY: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 27: GERMANY: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 28: GERMANY: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 29: U.K.: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 30: U.K.: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: U.K.: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 32: FRANCE: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 33: FRANCE: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 34: FRANCE: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 35: REST OF EUROPE: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 36: REST OF EUROPE: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 37: REST OF EUROPE: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 38: ASIA-PACIFIC: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 39: ASIA-PACIFIC: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: ASIA-PACIFIC: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 41: REST OF THE WORLD: FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 42: REST OF THE WORLD: FERTILITY MONITORS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 43: REST OF THE WORLD: FERTILITY TESTING DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2013-2020 (USD MILLION)
  • TABLE 44: NEW PRODUCT LAUNCHES, 2013-2015
  • TABLE 45: AWARENESS PROGRAMS, 2013-2015
  • TABLE 46: AGREEMENTS, PARTNERSHIPS, AND EXPANSIONS, 2013-2015
  • TABLE 47: OTHER STRATEGIES, 2013-2015

LIST OF FIGURES

  • FIGURE 1: FERTILITY TESTING DEVICES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: FERTILITY TESTING DEVICES MARKET, 2015 & 2020 (USD MILLION)
  • FIGURE 5: FERTILITY TESTING DEVICES MARKET, BY PRODUCT AND TYPE, 2015 VS. 2020
  • FIGURE 6: FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE, 2015 VS. 2020
  • FIGURE 7: ASIA-PACIFIC MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 8: EMERGING COUNTRIES OFFER HIGH-GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 9: OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE GLOBAL MARKET
  • FIGURE 10: NORTH AMERICA PROJECTED TO HOLD THE HIGHEST SHARE IN THE GLOBAL MARKET TILL 2020
  • FIGURE 11: FERTILITY TESTING DEVICES MARKET SEGMENTATION
  • FIGURE 12: FERTILITY TESTING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 13: MEDIAN AGE FOR FIRST PREGNANCY IS RISING ACROSS THE GLOBE, 2000-2020
  • FIGURE 14: WORLD FERTILITY RATE IS WITNESSING SHARP DECLINE: FORECAST TO 2050
  • FIGURE 15: RISING MEDIAN AGE OF FIRST-TIME PREGNANCIES IN WOMEN TO DRIVE THE MARKET GROWTH FOR FERTILITY TESTING DEVICES
  • FIGURE 16: INCREASING INFLOW OF GENERIC FERTILITY TESTING DEVICES RESTRAINS THE MARKET GROWTH
  • FIGURE 17: HIGH PREVALENCE OF INFERTILITY AMONG WOMEN (AGES 20-44) IN EMERGING NATIONS, IN 2010
  • FIGURE 18: EMERGENCE OF COMBINED KITS FOR DUAL TESTING OF PREGNANCY AND OVULATION OFFER LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 19: INCREASING TREND VOLUNTARY CHILDLESSNESS IN COUPLES IS A CHALLENGE FOR THE MARKET GROWTH
  • FIGURE 20: OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE GLOBAL FERTILITY TESTING DEVICES MARKET IN 2015
  • FIGURE 21: NON-PRESCRIPTION OR OTC-BASED SEGMENT WILL DOMINATE THE MARKET GROWTH
  • FIGURE 22: GEOGRAPHIC SNAPSHOT (2015): ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICAN MARKET SNAPSHOT
  • FIGURE 24: POLICIES ACROSS KEY EUROPEAN COUNTRIES TO PROMOTE BIRTH RATE
  • FIGURE 25: EUROPEAN MARKET SNAPSHOT
  • FIGURE 26: ASIA-PACIFIC MARKET SNAPSHOT
  • FIGURE 27: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY FROM 2013 TO 2015
  • FIGURE 28: FERTILITY TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 29: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
  • FIGURE 30: CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT
  • FIGURE 31: PRESTIGE BRANDS HOLDINGS, INC.: COMPANY SNAPSHOT
  • FIGURE 32: TAIDOC TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
  • FIGURE 33: GERATHERM MEDICAL AG: COMPANY SNAPSHOT
  • FIGURE 34: MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT
  • FIGURE 35: MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
Back to Top